美股异动｜雅培跌超2.6%，Q3营收略低于预期，收窄全年盈利指引

Core Viewpoint - Abbott Laboratories (ABT.US) reported a decline of over 2.6% in stock price, closing at $129.22 following the release of its Q3 earnings, which slightly missed analyst expectations for revenue [1] Financial Performance - Revenue for Q3 was $11.37 billion, slightly below the average analyst expectation of $11.4 billion [1] - Earnings per share (EPS) were reported at $1.30, which met analyst expectations [1] Future Guidance - The company expects full-year EPS to be in the range of $5.12 to $5.18, an increase from the previous guidance of $5.10 to $5.20 [1]